COVID-19 vaccine candidates: A review

被引:0
作者
Biala, Martyna [1 ]
Lelonek, Edyta [2 ]
Knysz, Brygida [1 ]
机构
[1] Wroclaw Med Univ, Dept Infect Dis Liver Dis & Acquired Immune Defic, Koszarowa 5, PL-51149 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept & Clin Dermatol Venereol & Allergol, Wroclaw, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2021年 / 75卷
关键词
coronavirus; COVID-19; SARS-CoV-2; vaccine; RESPIRATORY SYNDROME SARS; CLINICAL-FEATURES; CORONAVIRUS; EPIDEMIOLOGY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In December 2019 the first cases of atypical pneumonia caused by a novel coronavirus SARS-CoV-2 were reported in Wuhan, China. This new infection was called coronavirus disease 2019 (COVID-19). SARS-CoV-2 is primarily transmitted human-to-human via direct contact and via the air-respiratory droplets and/or aerosols. The clinical manifestations of COVID-19 could range from asymptomatic or mild non-specific symptoms to severe pneumonia with multiple organ failure and death. The virus spread rapidly to almost all the countries in the world within a few months, and on the 11th of March 2020, the World Health Organization (WHO) announced the COVID-19 pandemic. Since then, a dynamic increase in the number of COVID-19 infections and deaths has been recorded worldwide. The COVID-19 pandemic is accelerating and causing annex tensive impact on the functioning of health care and is also leading to an economic crisis in the world. Today, it is difficult to ultimately assess the long-term effects of the pandemic, although it is known that they will be experienced for decades. Therefore, the most important goal is to stop the pandemic and develop an effective vaccine against SARS-CoV-2. Using the ClinicalTrials.gov and World Health Organization databases, we shed light on the current worldwide clinical and pre-clinical trials in search for a COVID-19 vaccine.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 40 条
[1]  
Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]
[2]   MERS-CoV as an emerging respiratory illness: A review of prevention methods [J].
Baharoon, Salim ;
Memish, Ziad A. .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2019, 32
[3]   Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area [J].
Booth, CM ;
Matukas, LM ;
Tomlinson, GA ;
Rachlis, AR ;
Rose, DB ;
Dwosh, HA ;
Walmsley, SL ;
Mazzulli, T ;
Avendano, M ;
Derkach, P ;
Ephtimios, IE ;
Kitai, I ;
Mederski, BD ;
Shadowitz, SB ;
Gold, WL ;
Hawryluck, LA ;
Rea, E ;
Chenkin, JS ;
Cescon, DW ;
Poutanen, SM ;
Detsky, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2801-2809
[4]   Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development [J].
Calina, Daniela ;
Sarkar, Chandan ;
Arsene, Andreea Letitia ;
Salehi, Bahare ;
Docea, Anca Oana ;
Mondal, Milon ;
Islam, Muhammad Torequl ;
Zali, Alireza ;
Sharifi-Rad, Javad .
IMMUNOLOGIC RESEARCH, 2020, 68 (06) :315-324
[5]   Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review) [J].
Calina, Daniela ;
Docea, Anca Oana ;
Petrakis, Demetrios ;
Egorov, Alex M. ;
Ishmukhametov, Aydar A. ;
Gabibov, Alexsandr G. ;
Shtilman, Michael, I ;
Kostoff, Ronald ;
Carvalho, Felix ;
Vinceti, Marco ;
Spandidos, Demetrios A. ;
Tsatsakis, Aristidis .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (01) :3-16
[6]   THE TIME COURSE OF THE IMMUNE-RESPONSE TO EXPERIMENTAL CORONAVIRUS INFECTION OF MAN [J].
CALLOW, KA ;
PARRY, HF ;
SERGEANT, M ;
TYRRELL, DAJ .
EPIDEMIOLOGY AND INFECTION, 1990, 105 (02) :435-446
[7]   Disappearance of antibodies to SARS-associated coronavirus after recovery [J].
Cao, Wu-Chun ;
Liu, Wei ;
Zhang, Pan-He ;
Zhang, Fang ;
Richardus, Jan H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (11) :1162-1163
[8]   A strategic approach to COVID-19 vaccine R&D [J].
Corey, Lawrence ;
Mascola, John R. ;
Fauci, Anthony S. ;
Collins, Francis S. .
SCIENCE, 2020, 368 (6494) :948-950
[9]   Outbreak of a novel coronavirus [J].
Du Toit, Andrea .
NATURE REVIEWS MICROBIOLOGY, 2020, 18 (03) :123-123
[10]   Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial [J].
Folegatti, Pedro M. ;
Ewer, Katie J. ;
Aley, Parvinder K. ;
Angus, Brian ;
Becker, Stephan ;
Belij-Rammerstorfer, Sandra ;
Bellamy, Duncan ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Clutterbuck, Elizabeth A. ;
Dold, Christina ;
Faust, Saul N. ;
Finn, Adam ;
Flaxman, Amy L. ;
Hallis, Bassam ;
Heath, Paul ;
Jenkin, Daniel ;
Lazarus, Rajeka ;
Makinson, Rebecca ;
Minassian, Angela M. ;
Pollock, Katrina M. ;
Ramasamy, Maheshi ;
Robinson, Hannah ;
Snape, Matthew ;
Tarrant, Richard ;
Voysey, Merryn ;
Green, Catherine ;
Douglas, Alexander D. ;
Hill, Adrian V. S. ;
Lambe, Teresa ;
Gilbert, Sarah C. ;
Pollard, Andrew J. .
LANCET, 2020, 396 (10249) :467-478